August Physician Focus: Common Eye Disorders

Eye injuries and disorders can occur at any time of life, but with age comes a greater incidence of vision impairment. IMG_0685_editedToday, nearly three million people have glaucoma, nearly 25 million have cataracts, and almost 10 million combined have macular degeneration and diabetic retinopathy.

As the U.S. population ages, however, these age-related diseases are expected to increase dramatically. Macular degeneration and diabetic retinopathy, for example, are projected to double and quadruple, respectively, in the next 25 years.

To highlight these disorders, the August episode of Physician Focus with the Massachusetts Medical Society features two ophthalmologists from Eye Health Services of Quincy who are members of the Massachusetts Society of Eye Physicians and Surgeons (MSEPS).

Guests for the program are John T. H. Mandeville, M.D., Ph.D., (photo, center) a specialist in cosmetic and reconstructive eye plastic surgery and president of MSEPS; and Gerri L. Goodman, M.D., (right) a corneal specialist and member of the Boards of Directors of MSEPS and the New England Chapter of the Glaucoma Foundation. They join host B. Dale Magee, M.D., (left) past president of the Massachusetts Medical Society, for the discussion.

Among the topics of conversation are details on the four common conditions of cataracts, macular degeneration, glaucoma, and diabetic retinopathy; the distinctions among different eye care health professionals; the components of the eye and how it is structured; how to use an Amsler grid to check for macular degeneration; descriptions and photographs of what vision is like with the above conditions, and treatment options for the four disorders.  The physicians also discuss steps everyone should take, regardless of age, to practice good eye health and safety.

Physician Focus, now in its 11th consecutive year of production, is available for viewing on public access television stations throughout Massachusetts. It is also available online at,, and on YouTube.

Comments are closed.